Alaunos Therapeutics earnings were -$4.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TCRT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$742.0k, down 34.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TCRT reported annual earnings of -$4.7M, with -86.7% growth. The next TCRT earnings date is May 13, 2025.
Alaunos Therapeutics Earnings Reports & History FAQ
What were Alaunos Therapeutics's earnings last quarter?
On TCRT's earnings call on Invalid Date, Alaunos Therapeutics (NASDAQ: TCRT) reported Q4 2024 earnings per share (EPS) of -$0.46, up 90.61% year over year. Total TCRT earnings for the quarter were -$742.00 thousand. In the same quarter last year, Alaunos Therapeutics's earnings per share (EPS) was -$4.90.
The next TCRT earnings date is Invalid Date. Add TCRT to your watchlist to be reminded of Alaunos Therapeutics's next earnings date.
What was TCRT's earnings growth in the past year?
As of Alaunos Therapeutics's earnings date in Invalid Date, Alaunos Therapeutics's earnings has grown year over year. TCRT earnings in the past year totalled -$4.68 million.
Is Alaunos Therapeutics profitable or losing money?
As of the last Alaunos Therapeutics earnings report, Alaunos Therapeutics is currently losing money. Alaunos Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$4.68 million, a 86.68% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.